Literature DB >> 26547312

Management of thyroid gland invasion in laryngeal and hypopharyngeal squamous cell carcinoma.

Seçil Arslanoğlu1, Erdem Eren2, Yılmaz Özkul2, Ejder Ciğer2, Aylin Kopar2, Kazım Önal2, Demet Etit3, G Yazgı Tütüncü4.   

Abstract

The objective of this study was to determine the incidence of thyroid gland invasion in laryngeal and hypopharyngeal squamous cell carcinoma; and the association between clinicopathological parameters and thyroid gland invasion. Medical records of 75 patients with laryngeal and hypopharyngeal squamous cell carcinoma who underwent total laryngectomy with thyroidectomy were reviewed, retrospectively. Preoperative computed tomography scans, clinical and operative findings, and histopathological data of the specimens were evaluated. There were 73 male and two female patients with an age range of 41-88 years (mean 60.4 years). Hemithyroidectomy was performed in 62 (82.7 %) and total thyroidectomy was performed in 13 patients (17.3 %). Four patients had histopathologically proven thyroid gland invasion (5.3 %). In three patients, thyroid gland involvement was by means of direct invasion. Thyroid gland invasion was significantly correlated with thyroid cartilage invasion. Therefore, prophylactic thyroidectomy should not be a part of the treatment policy for these tumors.

Entities:  

Keywords:  Hypopharynx; Larynx; Squamous cell carcinoma; Thyroid gland

Mesh:

Year:  2015        PMID: 26547312     DOI: 10.1007/s00405-015-3828-x

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  26 in total

1.  Thyroid gland involvement in advanced laryngeal cancer: association with clinical and pathologic characteristics.

Authors:  Ohad Hilly; Raanan Raz; Yona Vaisbuch; Yulia Strenov; Karl Segal; Rumelia Koren; Jacob Shvero
Journal:  Head Neck       Date:  2011-12-16       Impact factor: 3.147

2.  Squamous cell carcinoma of the subglottis.

Authors:  Jimmy Garas; W Fred McGuirt
Journal:  Am J Otolaryngol       Date:  2006 Jan-Feb       Impact factor: 1.808

3.  Necessity of routine ipsilateral hemithyroidectomy during laryngopharyngectomy for pyriform sinus cancer.

Authors:  Ozan B Ozgursoy; John R Jacobs
Journal:  Am J Otolaryngol       Date:  2012-02-29       Impact factor: 1.808

4.  Thyroid gland invasion in laryngopharyngeal squamous cell carcinoma: prevalence, endoscopic and CT predictors.

Authors:  L Gaillardin; P Beutter; J-P Cottier; F Arbion; S Morinière
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2011-07-27       Impact factor: 2.080

5.  Risk factors associated with hypothyroidism after laryngectomy.

Authors:  R L Gal; T J Gal; D W Klotch; A B Cantor
Journal:  Otolaryngol Head Neck Surg       Date:  2000-09       Impact factor: 3.497

6.  Intraoperative management of the thyroid gland in laryngeal cancer surgery.

Authors:  B Dadas; B Uslu; B Cakir; H C Ozdoğan; A B Caliş; S Turgut
Journal:  J Otolaryngol       Date:  2001-06

7.  Indications for performing hemithyroidectomy for tumors requiring total laryngectomy.

Authors:  M A Biel; R H Maisel
Journal:  Am J Surg       Date:  1985-10       Impact factor: 2.565

8.  The role of thyroidectomy in advanced laryngeal and pharyngolaryngeal carcinoma.

Authors:  D Dequanter; M Shahla; P Paulus; N Vercruysse; Ph Lothaire
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-08-21

9.  Management of thyroid gland invasion in laryngopharyngeal cancer.

Authors:  Jae Won Kim; Gil Soo Han; Sung Soo Byun; Dong Youl Lee; Byung Han Cho; Young-Mo Kim
Journal:  Auris Nasus Larynx       Date:  2007-09-11       Impact factor: 1.863

10.  Thyroid gland in carcinoma of the larynx and hypopharynx: analysis of factors indicating thyroidectomy.

Authors:  Ramesh Kumar Gurunathan; Naresh K Panda; Ashim Das; Saravanan Karuppiah
Journal:  J Otolaryngol Head Neck Surg       Date:  2008-06
View more
  1 in total

1.  Management of the thyroid gland during laryngectomy.

Authors:  S X Li; M A Polacco; B J Gosselin; L X Harrington; A J Titus; J A Paydarfar
Journal:  J Laryngol Otol       Date:  2017-06-08       Impact factor: 1.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.